{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:27:15Z","timestamp":1786577235846,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI radiopharm. chem."],"DOI":"10.1186\/s41181-026-00459-7","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T04:16:11Z","timestamp":1780805771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding 68Ga radiolabeling capacity: off-label use of PSMA-11 single vial cold kits through aliquoting and dual generator utilization"],"prefix":"10.1186","volume":"11","author":[{"given":"Olivier","family":"Perrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Benkhoris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne","family":"Vanney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Barthelemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Boudousq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Deshayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Guisset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Soulairol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Rubira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Fersing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4350-8444","authenticated-orcid":false,"given":"Daniele","family":"Aliz\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"459_CR1","unstructured":"Absolute numbers. Incidence, Males, in 2022 - Global Cancer Observatory [Internet]. Glob Cancer Obs. 2022. https:\/\/gco.iarc.who.int\/today\/"},{"key":"459_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","volume":"40","author":"A Afshar-Oromieh","year":"2013","unstructured":"Afshar-Oromieh A, Malcher A, Eder M, Eisenhut M, Linhart HG, Hadaschik BA, et al. PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur J Nucl Med Mol Imaging. 2013;40:486\u201395. https:\/\/doi.org\/10.1007\/s00259-012-2298-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"459_CR43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/00006231-199903000-00013","volume":"20","author":"RJ Baker","year":"1999","unstructured":"Baker RJ. Preparation and properties of 99Tcm-exametazime using stannous ion augmentation of fractionated cold kits. Nucl Med Commun. 1999;20:287\u201394. https:\/\/doi.org\/10.1097\/00006231-199903000-00013.","journal-title":"Nucl Med Commun"},{"key":"459_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1874471013666201224113651","volume":"14","author":"KV Becker","year":"2021","unstructured":"Becker KV, Chernysheva M, Barnhart TE, Gagnon K, Engle JW. A Review of Accelerator-Produced Ga-68 with Solid Targets. Curr Radiopharm. 2021;14:315\u201324. https:\/\/doi.org\/10.2174\/1874471013666201224113651.","journal-title":"Curr Radiopharm"},{"key":"459_CR21","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s00259-004-1702-y","volume":"32","author":"WAP Breeman","year":"2005","unstructured":"Breeman WAP, De Jong M, De Blois E, Bernard BF, Konijnenberg M, Krenning EP. Radiolabelling DOTA-peptides with 68Ga. Eur J Nucl Med Mol Imaging. 2005;32:478\u201385. https:\/\/doi.org\/10.1007\/s00259-004-1702-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"459_CR9","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2967\/jnumed.119.231605","volume":"61","author":"L Calderoni","year":"2020","unstructured":"Calderoni L, Farolfi A, Pianori D, Maietti E, Cabitza V, Lambertini A, et al. Evaluation of an Automated Module Synthesis and a Sterile Cold Kit\u2013Based Preparation of 68Ga-PSMA-11 in Patients with Prostate Cancer. J Nucl Med. 2020;61:716. https:\/\/doi.org\/10.2967\/jnumed.119.231605.","journal-title":"J Nucl Med"},{"key":"459_CR17","doi-asserted-by":"publisher","DOI":"10.23736\/S1824-4785.17.02965-X","author":"C Decristoforo","year":"2017","unstructured":"Decristoforo C, Penuelas I, Patt M, Todde S. European regulations for the introduction of novel radiopharmaceuticals in the clinical setting. Q J Nucl Med Mol Imaging [Internet]. 2017. https:\/\/doi.org\/10.23736\/S1824-4785.17.02965-X. [cited 2025 Mar 10];61.","journal-title":"Q J Nucl Med Mol Imaging [Internet]"},{"key":"459_CR46","first-page":"1912","volume":"37","author":"C Decristoforo","year":"1996","unstructured":"Decristoforo C, Riccabona G. Problems with fractionated cold kits. J Nucl Med Off Publ Soc Nucl Med. 1996;37:1912\u20133.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"459_CR35","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3390\/ph16111544","volume":"16","author":"F Durieux","year":"2023","unstructured":"Durieux F, Dekyndt B, Legrand J-F, Rogeau A, Malek E, Semah F, et al. Optimization of Automated Radiosynthesis of Gallium-68-Labeled PSMA11 with Two [68Ge]Ge\/[68Ga]Ga Generators: Fractional Elution or Prepurification? Pharmaceuticals. 2023;16:1544. https:\/\/doi.org\/10.3390\/ph16111544.","journal-title":"Pharmaceuticals"},{"key":"459_CR3","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/ph7070779","volume":"7","author":"M Eder","year":"2014","unstructured":"Eder M, Neels O, M\u00fcller M, Bauder-W\u00fcst U, Remde Y, Sch\u00e4fer M, et al. Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer. Pharmaceuticals. 2014;7:779\u201396. https:\/\/doi.org\/10.3390\/ph7070779.","journal-title":"Pharmaceuticals"},{"key":"459_CR11","unstructured":"EMA LOCAMETZ - European Public Assessment Report. - Product Information.pdf [Internet]. 2022. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/locametz-epar-product-information_en.pdf"},{"key":"459_CR28","unstructured":"European, Pharmacopeia. Monograph Gallium (68Ga) Chloride Solution for Radiolabelling (01\/2021:2464). [Internet]. European Pharmacopeia, 11th Edition; 2020. https:\/\/extranet.edqm.eu\/4DLink1\/4DCGI\/Web_View\/mono\/2464"},{"key":"459_CR29","unstructured":"European Pharmacopoeia Monograph Gallium (68Ga) chloride solution produced by cyclotron (04\/2023:3109) [Internet]. European Pharmacopeia, 11th Edition. 2023. https:\/\/extranet.edqm.eu\/4DLink1\/4DCGI\/Web_View\/mono\/3109"},{"key":"459_CR4","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","volume":"44","author":"WP Fendler","year":"2017","unstructured":"Fendler WP, Eiber M, Beheshti M, Bomanji J, Ceci F, Cho S, et al. 68Ga-PSMA PET\/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2017;44:1014\u201324. https:\/\/doi.org\/10.1007\/s00259-017-3670-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"459_CR5","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1200\/JCO-25-00007","volume":"43","author":"R Garje","year":"2025","unstructured":"Garje R, Riaz IB, Naqvi SAA, Rumble RB, Taplin M-E, Kungel TM, et al. Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update. J Clin Oncol. 2025;43:2311\u201334. https:\/\/doi.org\/10.1200\/JCO-25-00007.","journal-title":"J Clin Oncol"},{"key":"459_CR10","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1007\/s00259-023-06287-0","volume":"50","author":"F Gelardi","year":"2023","unstructured":"Gelardi F, Briganti A, Pini C, Ninatti G, Gandaglia G, Montorsi F, et al. European guidelines update on PSMA PET\/CT for prostate cancer staging\u2014snap back to reality. Eur J Nucl Med Mol Imaging. 2023;50:2572\u20135. https:\/\/doi.org\/10.1007\/s00259-023-06287-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"459_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41181-021-00123-2","volume":"6","author":"N Gillings","year":"2021","unstructured":"Gillings N, Hjelstuen O, Ballinger J, Behe M, Decristoforo C, Elsinga P, et al. Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals. EJNMMI Radiopharm Chem. 2021;6:8. https:\/\/doi.org\/10.1186\/s41181-021-00123-2.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"459_CR31","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1097\/MNM.0000000000001232","volume":"41","author":"H Golan","year":"2020","unstructured":"Golan H, Esa M, Moshkoviz K, Feldhaim A, Hoch B, Shalom E. Enhancing capacity and synthesis of [68Ga]68-Ga-PSMA-HBED-CC with the lyophilized ready-to-use kit for nuclear pharmacy applications. Nucl Med Commun. 2020;41:986\u201390. https:\/\/doi.org\/10.1097\/MNM.0000000000001232.","journal-title":"Nucl Med Commun"},{"key":"459_CR12","unstructured":"ILLUCCIX (Kit for the preparation of Ga-68 GLU-UREA-LYS(AHX)-HBED-CC). Injection - Australian Product Information [Internet]. 2021. https:\/\/illuccix.com.au\/wp-content\/uploads\/Illuccix-Australian-Product-Information-PI.pdf"},{"key":"459_CR13","unstructured":"ISOPROTRACE, -. SUMMARY OF PRODUCT CHARACTERISTICS - Netherlands. 2024."},{"key":"459_CR6","unstructured":"Janneau I, Couturier O-F. Rapport d\u2019activit\u00e9 2023 - Soci\u00e9t\u00e9 Fran\u00e7aise de M\u00e9decine Nucl\u00e9aire [Internet]. 2023. https:\/\/www.cnp-mn.fr\/enquetes-nationales\/"},{"key":"459_CR36","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/jlcr.3879","volume":"63","author":"J Kleynhans","year":"2020","unstructured":"Kleynhans J, Rubow S, Le Roux J, Marjanovic-Painter B, Zeevaart JR, Ebenhan T. Production of [68 Ga]Ga\u2010PSMA: Comparing a manual kit\u2010based method with a module\u2010based automated synthesis approach. J Label Compd Radiopharm. 2020;63:553\u201363. https:\/\/doi.org\/10.1002\/jlcr.3879.","journal-title":"J Label Compd Radiopharm"},{"key":"459_CR8","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1038\/s41598-020-60099-y","volume":"10","author":"MM Kurash","year":"2020","unstructured":"Kurash MM, Gill R, Khairulin M, Harbosh H, Keidar Z. 68Ga-labeled PSMA-11 (68Ga-isoPROtrace-11) synthesized with ready to use kit: normal biodistribution and uptake characteristics of tumour lesions. Sci Rep. 2020;10:3109. https:\/\/doi.org\/10.1038\/s41598-020-60099-y.","journal-title":"Sci Rep"},{"key":"459_CR48","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1134\/S1066362218060103","volume":"60","author":"AA Larenkov","year":"2018","unstructured":"Larenkov AA, Maruk AYa, Kodina GE. Intricacies of the Determination of the Radiochemical Purity of 68Ga Preparations: Possibility of Sorption of Ionic 68Ga Species on Reversed-Phase Columns. Radiochemistry. 2018;60:625\u201333. https:\/\/doi.org\/10.1134\/S1066362218060103.","journal-title":"Radiochemistry"},{"key":"459_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/diagnostics8010016","volume":"8","author":"N Lenzo","year":"2018","unstructured":"Lenzo N, Meyrick D, Turner J. Review of Gallium-68 PSMA PET\/CT Imaging in the Management of Prostate Cancer. Diagnostics. 2018;8:16. https:\/\/doi.org\/10.3390\/diagnostics8010016.","journal-title":"Diagnostics"},{"key":"459_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/diagnostics8010016","volume":"8","author":"NP Lenzo","year":"2018","unstructured":"Lenzo NP, Meyrick D, Turner JH. Review of Gallium-68 PSMA PET\/CT Imaging in the Management of Prostate Cancer. Diagnostics. 2018;8:16. https:\/\/doi.org\/10.3390\/diagnostics8010016.","journal-title":"Diagnostics"},{"key":"459_CR24","doi-asserted-by":"publisher","first-page":"812050","DOI":"10.3389\/fmed.2022.812050","volume":"9","author":"N Lepareur","year":"2022","unstructured":"Lepareur N. Cold Kit Labeling: The Future of 68Ga Radiopharmaceuticals? Front Med. 2022;9:812050. https:\/\/doi.org\/10.3389\/fmed.2022.812050.","journal-title":"Front Med"},{"key":"459_CR38","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1016\/j.apradiso.2012.05.009","volume":"70","author":"M Lin","year":"2012","unstructured":"Lin M, Ranganathan D, Mori T, Hagooly A, Rossin R, Welch MJ, et al. Long-term evaluation of TiO2-based 68Ge\/68Ga generators and optimized automation of [68Ga]DOTATOC radiosynthesis. Appl Radiat Isot. 2012;70:2539\u201344. https:\/\/doi.org\/10.1016\/j.apradiso.2012.05.009.","journal-title":"Appl Radiat Isot"},{"key":"459_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00259-023-06466-z","volume":"51","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li L, Qin Y, Chen Z, Zhao H, Wang X, et al. Total-body PET\/CT with half-dose [68 Ga]Ga-PSMA-11 for biochemical recurrent prostate cancer: comparable diagnostic value to short axial field-of-view PET\/CT with full-dose [68 Ga]Ga-PSMA-11. Eur J Nucl Med Mol Imaging. 2024;51:581\u20139. https:\/\/doi.org\/10.1007\/s00259-023-06466-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"459_CR41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s41181-021-00149-6","volume":"6","author":"G Luurtsema","year":"2021","unstructured":"Luurtsema G, Pichler V, Bongarzone S, Seimbille Y, Elsinga P, Gee A, et al. EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging quality. EJNMMI Radiopharm Chem. 2021;6:34. https:\/\/doi.org\/10.1186\/s41181-021-00149-6.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"459_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/jlcr.3821","volume":"63","author":"M Meisenheimer","year":"2020","unstructured":"Meisenheimer M, K\u00fcrpig S, Essler M, Eppard E. Manual vs automated 68 Ga-radiolabelling-A comparison of optimized processes. J Label Compd Radiopharm. 2020;63:162\u201373. https:\/\/doi.org\/10.1002\/jlcr.3821.","journal-title":"J Label Compd Radiopharm"},{"key":"459_CR15","doi-asserted-by":"publisher","unstructured":"Meisenheimer M, Saenko Y, Eppard E. Gallium-68: Radiolabeling of Radiopharmaceuticals for PET Imaging - A Lot to Consider. In: Ali Raza Naqvi S, Babar Imrani M, editors. Med Isot. IntechOpen; 2021. https:\/\/doi.org\/10.5772\/intechopen.90615","DOI":"10.5772\/intechopen.90615"},{"key":"459_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.mednuc.2023.07.002","volume":"47","author":"V Nataf","year":"2023","unstructured":"Nataf V, Cross T, Blanc-Beguin F. Le gallium-68, de la production \u00e0 la gestion des d\u00e9chets. M\u00e9decine Nucl. 2023;47:247\u201357. https:\/\/doi.org\/10.1016\/j.mednuc.2023.07.002.","journal-title":"M\u00e9decine Nucl"},{"key":"459_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s41181-022-00180-1","volume":"7","author":"BJB Nelson","year":"2022","unstructured":"Nelson BJB, Andersson JD, Wuest F, Spreckelmeyer S. Good practices for 68Ga radiopharmaceutical production. EJNMMI Radiopharm Chem. 2022;7:27. https:\/\/doi.org\/10.1186\/s41181-022-00180-1.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"459_CR44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/00006231-200005000-00010","volume":"21","author":"S Penglis","year":"2000","unstructured":"Penglis S, Tsopelas C. 99Tcm-tetrofosmin: Evaluation of fractionated cold kits and two new methods of quality control. Nucl Med Commun. 2000;21:469\u201372. https:\/\/doi.org\/10.1097\/00006231-200005000-00010.","journal-title":"Nucl Med Commun"},{"key":"459_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s41181-020-00106-9","volume":"5","author":"ME Rodnick","year":"2020","unstructured":"Rodnick ME, Sollert C, Stark D, Clark M, Katsifis A, Hockley BG, et al. Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target. EJNMMI Radiopharm Chem. 2020;5:25. https:\/\/doi.org\/10.1186\/s41181-020-00106-9.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"459_CR42","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/s41596-021-00662-7","volume":"17","author":"ME Rodnick","year":"2022","unstructured":"Rodnick ME, Sollert C, Stark D, Clark M, Katsifis A, Hockley BG, et al. Synthesis of 68Ga-radiopharmaceuticals using both generator-derived and cyclotron-produced 68Ga as exemplified by [68Ga]Ga-PSMA-11 for prostate cancer PET imaging. Nat Protoc. 2022;17:980\u20131003. https:\/\/doi.org\/10.1038\/s41596-021-00662-7.","journal-title":"Nat Protoc"},{"key":"459_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00259-003-1330-y","volume":"31","author":"A S\u00e1nchez-Crespo","year":"2004","unstructured":"S\u00e1nchez-Crespo A, Andreo P, Larsson SA. Positron flight in human tissues and its influence on PET image spatial resolution. Eur J Nucl Med Mol Imaging. 2004;31:44\u201351. https:\/\/doi.org\/10.1007\/s00259-003-1330-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"459_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13550-014-0036-4","volume":"4","author":"F Sudbrock","year":"2014","unstructured":"Sudbrock F, Fischer T, Zimmermanns B, Guliyev M, Dietlein M, Drzezga A, et al. Characterization of SnO2-based 68Ge\/68Ga generators and 68Ga-DOTATATE preparations: radionuclide purity, radiochemical yield and long-term constancy. EJNMMI Res. 2014;4:36. https:\/\/doi.org\/10.1186\/s13550-014-0036-4.","journal-title":"EJNMMI Res"},{"key":"459_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41181-020-00114-9","volume":"6","author":"H Thisgaard","year":"2021","unstructured":"Thisgaard H, Kumlin J, Langkj\u00e6r N, Chua J, Hook B, Jensen M, et al. Multi-curie production of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE. EJNMMI Radiopharm Chem. 2021;6:1. https:\/\/doi.org\/10.1186\/s41181-020-00114-9.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"459_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/ijnm.ijnm_115_21","volume":"37","author":"AK Thokchom","year":"2022","unstructured":"Thokchom AK, Kumar R, Bharati S. Vasumathi null. Quality Assessment of Tc-99m Methylene Diphosphonate (MDP) Radiopharmaceutical Prepared Using Different Cold Kit Fractionation Methods. Indian J Nucl Med IJNM Off J Soc Nucl Med India. 2022;37:7\u201311. https:\/\/doi.org\/10.4103\/ijnm.ijnm_115_21.","journal-title":"Indian J Nucl Med IJNM Off J Soc Nucl Med India"},{"key":"459_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41181-017-0025-9","volume":"2","author":"S Todde","year":"2017","unstructured":"Todde S, Peitl PK, Elsinga P, Koziorowski J, Ferrari V, Ocak EM, et al. Guidance on validation and qualification of processes and operations involving radiopharmaceuticals. EJNMMI Radiopharm Chem. 2017;2:8. https:\/\/doi.org\/10.1186\/s41181-017-0025-9.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"459_CR34","doi-asserted-by":"publisher","first-page":"49586","DOI":"10.1039\/C7RA09076E","volume":"7","author":"MI Tsionou","year":"2017","unstructured":"Tsionou MI, Knapp CE, Foley CA, Munteanu CR, Cakebread A, Imberti C, et al. Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling. RSC Adv. 2017;7:49586\u201399. https:\/\/doi.org\/10.1039\/C7RA09076E.","journal-title":"RSC Adv"},{"key":"459_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s41181-024-00260-4","volume":"9","author":"EA Van Brandwijk","year":"2024","unstructured":"Van Brandwijk EA, Aalbersberg EA, Hosseini AS, Huitema ADR, Hendrikx JJMA. Automated radiolabelling of [68Ga]Ga-PSMA-11 (gallium (68Ga)-gozetotide) using the Locametz\u00ae kit and two generators. EJNMMI Radiopharm Chem. 2024;9:31. https:\/\/doi.org\/10.1186\/s41181-024-00260-4.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"459_CR47","unstructured":"Van Dyck H, Seibyl CP, Zubal J, Innis GB. R. Problems with Fractionated Cold Kits. J Nucl Med [Internet] 37\u00a0N\u00b011. 1996; https:\/\/jnm.snmjournals.org\/content\/37\/11\/1912.long"},{"key":"459_CR50","doi-asserted-by":"publisher","first-page":"019","DOI":"10.1055\/s-0045-1814733","volume":"25","author":"J Vanney","year":"2026","unstructured":"Vanney J, Torchio J, Renaud SC, Cadet MM, Rubira L, Fersing C. Scalable 68Ga Cold Kit Radiolabeling: High-Throughput Preparation of [68Ga]Ga-Edotreotide via Aliquoting and Dual Generator Strategy. World J Nucl Med. 2026;25:019\u201327. https:\/\/doi.org\/10.1055\/s-0045-1814733.","journal-title":"World J Nucl Med"},{"key":"459_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2174\/157340611796799195","volume":"7","author":"I Velikyan","year":"2011","unstructured":"Velikyan I. Positron Emitting [68Ga]Ga-Based Imaging Agents: Chemistry and Diversity. Med Chem. 2011;7:345\u201379. https:\/\/doi.org\/10.2174\/157340611796799195.","journal-title":"Med Chem"},{"key":"459_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13550-015-0105-3","volume":"5","author":"R Vis","year":"2015","unstructured":"Vis R, Lavalaye J, Van De Garde EM. GMP-compliant 68Ga radiolabelling in a conventional small-scale radiopharmacy: a feasible approach for routine clinical use. EJNMMI Res. 2015;5:27. https:\/\/doi.org\/10.1186\/s13550-015-0105-3.","journal-title":"EJNMMI Res"},{"key":"459_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s41181-024-00317-4","volume":"9","author":"IE Wang","year":"2024","unstructured":"Wang IE, Morrissette LJ, Wong KK, Brooks AF, Dakanali M, Scott PJH. A comparison of routine [68Ga]Ga-PSMA-11 preparation using Locametz and Illuccix kits. EJNMMI Radiopharm Chem. 2024;9:87. https:\/\/doi.org\/10.1186\/s41181-024-00317-4.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"459_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/jlcr.3993","volume":"65","author":"D Y\u00fcksel","year":"2022","unstructured":"Y\u00fcksel D, U\u011fur A. Comparison of three different methods in [68 Ga]Ga-PSMA11 radiolabeling. J Label Compd Radiopharm. 2022;65:272\u20139. https:\/\/doi.org\/10.1002\/jlcr.3993.","journal-title":"J Label Compd Radiopharm"}],"container-title":["EJNMMI Radiopharmacy and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41181-026-00459-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-026-00459-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-026-00459-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T22:44:52Z","timestamp":1786574692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41181-026-00459-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["459"],"URL":"https:\/\/doi.org\/10.1186\/s41181-026-00459-7","relation":{},"ISSN":["2365-421X"],"issn-type":[{"value":"2365-421X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"55"}}